Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.

Westendorf, J J; Jelinek, D F

Westendorf, J J; Jelinek, D F.

Affiliation

Westendorf JJ; Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.

J Immunol ; 157(7): 3081-8, 1996 Oct 01.

Article in En | MEDLINE | ID: mdl-8816418

Subject(s)

Gene Expression Regulation, Neoplastic; Multiple Myeloma/pathology; Neoplasm Proteins/biosynthesis; Peptide Biosynthesis; Antibodies, Monoclonal/pharmacology; Antigens, CD/immunology; Antigens, CD/pharmacology; Base Sequence; Cell Division; Ciliary Neurotrophic Factor; Cytokine Receptor gp130; Humans; Interleukin-6/antagonists & inhibitors; Interleukin-6/immunology; Interleukin-6/pharmacology; Membrane Glycoproteins/immunology; Membrane Glycoproteins/pharmacology; Molecular Sequence Data; Multiple Myeloma/metabolism; Neoplasm Proteins/genetics; Nerve Tissue Proteins/antagonists & inhibitors; Nerve Tissue Proteins/immunology; Oncostatin M; Peptides/genetics; Tumor Cells, Cultured

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptide Biosynthesis / Gene Expression Regulation, Neoplastic / Multiple Myeloma / Neoplasm Proteins Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Immunol Year: 1996 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links